• Successful US launch of EZZDAY brand with four products
• Entered 3-year Southeast Asia distribution deal with ROFA Enterprises
• Expanded Australian pharmacy footprint through Direct Chemist Outlet partnership

EZZ Life Science Holdings Ltd, a leading life science company, has reported its Quarterly Activities Report and Appendix 4C for the period ended 30 June 2025 (Q4 FY25). Key highlights include the successful launch of the EZZDAY brand in the United States, supported by local manufacturing and FDA registration. The initial EZZDAY product range includes four health supplements covering areas such as gut health, vaginal care, and detoxification. EZZ also entered a new three-year Southeast Asia distribution agreement with ROFA Enterprises, securing a minimum $21 million in purchase commitments over the contract term. This expands the company's presence in the growing regional market for premium health supplements. Domestically, EZZ enhanced its pharmacy footprint through a partnership with Direct Chemist Outlet, covering up to 130 new stores across Australia. The company also continued to strengthen its innovation pipeline, launching a new liquid calcium soft gel product. During the quarter, EZZ engaged the University of Sydney to undertake a two-year research study on the effects of a novel multi-ingredient nutritional supplement on bone health. Financially, EZZ reported robust operational performance, with customer receipts totaling $21.3 million, a 46% increase from the previous quarter. This translated into a positive cash inflow of $1.4 million for the period. The company closed Q4 FY25 with a strong cash balance of $20.8 million, remaining debt-free (excluding lease liabilities).

For FY26, EZZ expects to scale the EZZDAY brand in the US, drive performance in Southeast Asia under the ROFA distribution agreement, and accelerate growth across Australian retail channels. The company will also continue product innovation and explore targeted acquisition opportunities.

Looking ahead, EZZ remains focused on executing its global growth strategy through innovation, market expansion, and strategic partnerships. Key priorities for FY26 include scaling the EZZDAY brand in the US, driving performance in Southeast Asia, accelerating growth in Australian retail, and continuing product innovation.